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DNA Methylation Is a Critical Cell-Intrinsic
Determinant of Astrocyte Differentiation
in the Fetal Brain
family of cytokines that share gp130 as a signal-trans-
ducing receptor component (Taga and Kishimoto, 1997),
and bone morphogenetic protein 2 (BMP2), which be-
longs to the transforming growth factor  super-family,
act in synergy to induce astrocytogenesis of fetal mouse
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telencephalic neuroepithelial cells (Nakashima et al.,1 Department of Cell Fate Modulation, Institute
1999b). The synergistic action of LIF and BMP2 is medi-of Molecular Embryology and Genetics
ated by a complex formation of respective downstreamKumamoto University
transcription factors, signal transducer and activator ofKumamoto, 860-0811
transcription 3 (STAT3), and Smads, bridged by a tran-Japan
scriptional coactivator, p300 (Nakashima et al., 1999b).2 Department of Pediatrics
We have also shown that all the gp130-stimulating cyto-3 Department of Tumor Genetics and Biology
kines are expressed in the fetal mouse telencephalonKumamoto University School of Medicine
and have the potential to induce astrocyte differentiationKumamoto, 860-0811
of neuroepithelial cells through the activation of gp130Japan
(Ochiai et al., 2001; Yanagisawa et al., 1999, 2000). In4 Department of Pediatrics
addition, genetic ablation of gp130 resulted in a signifi-Gunma University School of Medicine
cant reduction in the number of astrocytes, assessed byGunma, 371-8511
expression of their marker, glial fibrillary acidic proteinJapan
(GFAP), in the developing brain, proving an essential role
for gp130-stimulating cytokines in the differentiation of
astrocytes in vivo (Nakashima et al., 1999a). STAT3 rec-Summary
ognition sequences have been identified within a regula-
tory region of the GFAP gene promoter which conferAstrocyte differentiation, which occurs late in brain
cell-specific expression (Bonni et al., 1997; Nakashimadevelopment, is largely dependent on the activation
et al., 1999b). Furthermore, within these potential STAT3of a transcription factor, STAT3. We show that
binding sites, a particular site between 1518 andastrocytes, as judged by glial fibrillary acidic protein
1510 is evolutionarily conserved between human, rat,(GFAP) expression, never emerge from neuroepithelial
and mouse GFAP genes and is important for GFAP ex-cells on embryonic day (E) 11.5 even when STAT3 is
pression by gp130-stimulating cytokines (Bonni et al.,activated, in contrast to E14.5 neuroepithelial cells. A
1997; Nakashima et al., 1999b). A point mutation in thisCpG dinucleotide within a STAT3 binding element in
STAT3 recognition sequence or forced expression of athe GFAP promoter is highly methylated in E11.5 neu-
dominant-negative form of STAT3 in neuroepithelialroepithelial cells, but is demethylated in cells respon-
cells abolishes the GFAP expression induced by gp130-sive to the STAT3 activation signal to express GFAP.
stimulating cytokines (Bonni et al., 1997; Nakashima etThis CpG methylation leads to inaccessibility of STAT3
al., 1999b; Ochiai et al., 2001; Rajan and McKay, 1998;to the binding element. We suggest that methylation
Takizawa et al., 2001; Yanagisawa et al., 1999, 2000).
of a cell type-specific gene promoter is a pivotal event
Thus, the expression of GFAP is largely dependent on
in regulating lineage specification in the developing
the activation of STAT3 and the presence of its particular
brain. recognition sequence in the promoter.
It should be noted, as shown in this paper, that even
Introduction when STAT3 is activated, not all cells express GFAP
and that the responsiveness of the GFAP gene promoter
Specification of cell lineages in the developing brain is to gp130 cytokines appears to be developmentally regu-
thought to be regulated by cell-external cues and cell- lated. Furthermore, neurons in the developing brain and
intrinsic programs (Edlund and Jessell, 1999). The cues cells outside the nervous system do not express GFAP
include various cytokines whose signals are transduced in response to STAT3 activation. This suggests the pres-
into the nucleus by transcription factors that bind to ence of a mechanism by which GFAP expression is
and activate their specific target gene promoters. The repressed in nonspecific cells. In addition, during mouse
programs are, in part, regulated by the epigenetic modi- development, neuronal differentiation starts at a very
fication of the cell type-specific genes. early stage and continues throughout brain develop-
Fetal telencephalic neuroepithelial cells contain neu- ment, while astrocytes appear just before term (Qian
ral precursors that give rise to neurons, astrocytes, and et al., 2000). The mechanism by which astrocytes are
oligodendrocytes (Anderson, 2001; Gage, 2000; McKay, prevented from differentiating at earlier stages in the
1997). We have previously demonstrated that leukemia developing brain has long been of interest. All of these
inhibitory factor (LIF), a member of the interleukin-6 (IL-6) observations suggest that there is a cell-intrinsic pro-
gram, most likely an epigenetic status, that determines
whether or not cells respond to astrocyte-inducing cell-5 Correspondence: taga@kaiju.medic.kumamoto-u.ac.jp [T.T.]; kin@
external cues.kaiju.medic.kumamoto-u.ac.jp [K.N.]
6These authors contributed equally to this work. Methylation of genomic DNA at CpG dinucleotides is
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a major epigenetic modification of mammalian genomes
which has been shown to be implicated in the regulation
of cell- or tissue-specific gene expression (Bird and
Wolffe, 1999). It also functions in some other aspects
of gene expression, such as genomic imprinting, X chro-
mosome inactivation, aging, and tumorigenesis (Bird
and Wolffe, 1999; Razin, 1998; Robertson and Jones,
2000). In these situations, CpG methylation contributes
generally to transcriptional suppression by preventing
transcriptional regulators from binding to their target
gene promoters, or by triggering the formation of inac-
tive chromatin. The former mechanism is known to occur
for transcriptional factors such as cMyb (Klempnauer,
1993), cMyc, E2F (Campanero et al., 2000), CREB (Weih
et al., 1991), AP2 (Comb and Goodman, 1990), NF-B
(Kirillov et al., 1996), and ETS, which are incapable of
binding to methylated forms of their recognition se-
quences. The latter mechanism is active suppression
mediated by proteins which have a methylated-CpG
binding domain (MBD) (Bird and Wolffe, 1999; Li, 1999).
They preferentially bind to methylated CpG and repress
gene transcription by recruiting histone deacetylases
(HDACs).
The methylation status of CpG dinucleotides within
the GFAP gene promoter in rat brain cells has been
shown to be lower during the developmental window
in which astrocytogenesis is predominantly occurring
(Condorelli et al., 1997; Teter et al., 1996). Highly frequent
methylation of seven CpG sites located between 1464
and 1170 in the rat GFAP promoter, where the se-
quence is well-conserved between rat, mouse, and hu-
man, was observed in nonneural tissues lacking GFAP
expression (Teter et al., 1994). Furthermore, methylation
frequency of a CpG site at 1176 in the GFAP promoter
was reported to be higher in the neuronal nuclei than
the glial nuclei of adult brain, as assessed using an
Figure 1. Failure of LIF-Induced GFAP Expression in E11.5 Neuro-incidentally applicable methylation-sensitive restriction
epithelial Cells and Postmitotic Neuronsenzyme to this site (Barresi et al., 1999). However, in
(A–D) Neuroepithelial cells prepared from E14.5 (A and B) or E11.5that paper, any relationship between this methylation
(C and D) mouse telencephalons cultured in the absence (A and C)and transcription factors was not discussed. These data
or presence (B and D) of LIF (80 ng/ml) for 4 days.
provided evidence that the methylation status of the (E–H) Neuroepithelial cells prepared from E14.5 cultured in the ab-
GFAP promoter varies among cell types and during de- sence (E and F) or presence (G and H) of AraC (1 M) for 4 days,
followed by incubation without (E and G) or with LIF (80 ng/ml) (Fvelopment, but the mechanism whereby CpG methyla-
and H) for 4 days.tion regulates expression of GFAP remains to be eluci-
Cells were stained with antibodies against GFAP (red) or MAP2dated.
(green). Bar  50 m.In the present paper, we have analyzed the mecha-
nisms underlying cell type- and developmental stage-
dependent responsiveness of the GFAP gene promoter
The observations in this study suggest how this astrocyte-to the gp130-STAT3 signal with respect to DNA methyla-
specific protein is exclusively expressed in this cell type,tion. We show that a CpG site in a particular STAT3
and provide insight into the mechanism underlying lin-recognition sequence between 1518 and 1510 in the
eage specification during brain development.GFAP promoter, which has been shown to be critical
for GFAP expression, is methylated in neurons but not
in astrocytes, the former of which do not express GFAP Results
even though STAT3 is activated. This site is also methyl-
ated in cells outside the nervous system which do not Developmental Stage-Dependent, Cell Type-Specific
normally express GFAP. We further show that, in neuro- Expression of GFAP in LIF-Stimulated Brain Cells
epithelial cells, this particular site becomes demethylated In the course of mouse development, neurons appear
at the stage when cells are responsive to the STAT3 from nearly the beginning of neuroectoderm formation
activation signal and express GFAP. We further demon- whereas astrocytes start to appear at a much later stage
strate that methylation of this CpG site in the STAT3 in brain development (Qian et al., 2000). We and others
recognition sequence within GFAP promoter abolishes have previously reported that astrocyte differentiation
can be induced in cultured fetal mouse neuroepithelialthe accessibility of STAT3 and transcriptional activation.
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cells prepared from, for example, E14.5 brain by gp130- showed that STAT3Y705F expression resulted in a dra-
matic reduction in GFAP expression, while the expres-stimulating cytokines (Bonni et al., 1997; Nakashima et
al., 1999c; Rajan and McKay, 1998). Figures 1A and 1B sion of the control protein (LacZ) did not change (Figures
2B–2G).show that GFAP-positive astrocytes were induced by
LIF in a culture of E14.5 neuroepithelial cells, as has been As we showed in Figure 1, E11.5 neuroepithelial cells
and postmitotic neurons did not express GFAP evenshown previously. In marked contrast, no astrocytes
appeared from E11.5 neuroepithelial cells cultured un- in the presence of LIF. Given that GFAP expression is
dependent on STAT3 activation, it was possible thatder the same conditions (Figures 1C and 1D). This result
suggests that the cellular status of E11.5 neuroepithelial STAT3 may not be activated in these cell populations
upon LIF stimulation. However, as depicted in Figure 2H,cells did not allow them to differentiate into astrocytes
in response to LIF. It should be noted in Figure 1B that STAT3 protein is expressed and activated in response to
LIF stimulation in E11.5 neuroepithelial cells and postmi-cells expressing a neuronal marker protein, MAP2 (mi-
crotubule-associated protein 2), did not express GFAP, totic neurons. This result suggests that a mechanism
other than failure of STAT3 activation underlies the im-and vice versa, suggesting that the expression of MAP2
and GFAP are mutually exclusive. pairment of GFAP expression in these cells in response
to signals activating gp130 and STAT3.We therefore wanted to discover whether differenti-
ated neurons do not respond to LIF by expressing GFAP.
In the telencephalon of E14.5 mice, neurogenesis is ac- The Critical STAT3 Site in the GFAP Gene Promoter
tive but gliogenesis has not yet started (Ghosh and Is Methylated in E11.5 Neuroepithelial Cells
Greenberg, 1995), indicating that cells which have with- and Postmitotic Neurons
drawn from the mitotic cycle at E14.5 are only neurons As mentioned above, one particular STAT3 binding
and not glial cells. Postmitotic neurons were enriched sequence (1518 to 1510) in the GFAP promoter is
by incubation of E14.5 telencephalic neuroepithelial cells essential for cells to express GFAP. We found a CpG
with 1 M of 1--D-arabinofuranosylcytosine (AraC) for 4 dinucleotide, a potential target for DNA methylation in
days to eliminate proliferating cells. In contrast to the mammals, within this sequence. We thus postulated that
results without AraC treatment (Figures 1E and 1F), post- this STAT3 binding sequence, which is critical for GFAP
mitotic neurons did not express GFAP (Figures 1G and expression, may be methylated in E11.5 neuroepithelial
1H), even in the presence of LIF. This result suggests cells and postmitotic neurons, since this type of epige-
the existence of as yet unknown mechanisms by which netic modification in genomic DNA has been shown to
the expression of the astrocyte-specific gene, GFAP, is confer transcriptional suppression, resulting in tissue-
prohibited in neurons. specific regulation of gene expression (Bird and Wolffe,
1999). In light of these findings, we sought to determine
whether methylation of the STAT3 binding element cor-
Activation of the gp130-STAT3 Pathway Is Not related with the regulation of GFAP expression.
Sufficient to Induce GFAP Expression in E11.5 We prepared postmitotic neurons from mouse E14.5
Neuroepithelial Cells and Postmitotic Neurons telencephalic neuroepithelial cells by elimination of pro-
In the mouse, rat, and human GFAP gene promoters, a liferating neural precursors with AraC treatment. To ex-
STAT3 binding element (TTCCGAGAA, 1518 to 1510 amine the methylation status of the critical STAT3 bind-
for mouse; see Figure 2A) is perfectly conserved (Bonni ing element, we used a bisulfite sequencing method
et al., 1997; Nakashima et al., 1999b). Introduction of which allows the determination of every methylated CpG
nucleic acid substitution in this site (CCAAGAGAA; site in any target sequence (Clark et al., 1994). As shown
GF1L-SBSPM) abolishes the LIF-induced GFAP pro- in Figure 3A, the CpG dinucleotide in the STAT3 binding
moter activation as shown in Figure 2A. We then gener- site in the GFAP promoter was highly methylated in
ated reporter constructs containing either the minimal postmitotic neurons (column 1), while that in the AraC-
promoter region of the GFAP gene alone (73 to 12; untreated control cells, which are capable of expressing
GFMP) or 8 repeats of the STAT3 binding element ap- GFAP in response to LIF stimulation, was barely methyl-
pended to the minimal promoter (SBS8GFMP) (Figure ated (column 2). When astrocytes were enriched by incu-
2A). Although the minimal promoter showed no re- bation of neuroepithelial cells with LIF and BMP2 simul-
sponse to LIF stimulation, 8 repeats of the STAT3 bind- taneously for 4 days (Nakashima et al., 1999b, 1999c),
ing element made it responsive to LIF (see SBS8GFMP a CpG site in the sequence was also barely methylated
in Figure 2A). Taken together with the previous finding (column 3). We further examined a possible develop-
that a dominant-negative form of STAT3 (STAT3Y705F) (Mi- mental change in the frequency of CpG methylation in
nami et al., 1996) abolished LIF-induced GFAP expres- the critical STAT3 binding site (1518 to 1510) in the
sion (Nakashima et al., 1999b), this suggests that not GFAP promoter in neuroepithelial cells. As shown in
only the activation of the STAT3 protein but also its Figure 3B, methylation of this particular STAT3 binding
binding to the particular site (i.e.,1518 to1510) in the site was very frequent in E11.5 neuroepithelial cells and
GFAP gene promoter are prerequisites for LIF-induced less frequent in E14.5 neuroepithelial cells. When the
GFAP expression in neuroepithelial cells. latter cells were cultured for 4 days in vitro, methylation
The importance of the gp130-STAT3 signaling path- of this site became very low. In E11.5 neuroepithelial
way in GFAP expression was then confirmed by infecting cells, over 50% of this site was still methylated after 4
neuroepithelial cells with a recombinant adenovirus gen- days in culture. The primary data from the experiments
erated to express STAT3Y705F. Staining with an antibody in Figure 3 are summarized in Table 1.
RT-PCR analysis of mRNA from adult tissues such asraised against GFAP after 4 days of LIF stimulation
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Figure 2. Requirement for STAT3 in LIF-
Induced Astrocyte Differentiation and Ac-
tivation of STAT3 in LIF-Nonresponsive
E11.5 Neuroepithelial Cells and Postmitotic
Neurons
(A) Neuroepithelial cells transfected with lu-
ciferase constructs containing the following
GFAP promoter regions: an intact 2.5 kb pro-
moter (GF1L), a 2.5 kb promoter with muta-
tions in its STAT3 recognition sequence
(1518 to 1510) (GF1L-SBSPM), a minimal
promoter region (GFMP) or a minimal pro-
moter region with 8 repeats of the STAT3
binding sequence (SBS8GFMP). On the fol-
lowing day, cells were stimulated with LIF (80
ng/ml) for 8 hr.
(B–G) Neuroepithelial cells infected with re-
combinant adenoviruses engineered to ex-
press LacZ (B–D) or FLAG-tagged STAT3Y705F
(E–G) stimulated with LIF. After 4 days, cells
were stained with antibodies against LacZ
(B), FLAG (E), or GFAP (C and F). Superim-
posed views of (B) and (C) and of (E) and (F)
are shown in (D) and (G), respectively. Bar 
50 m.
(H) Cell lysates from E11.5 neuroepithelial
cells (NEC) and postmitotic neurons after in-
cubation with or without LIF (100 ng/ml)
probed with antibodies against tyrosine-
phosphorylated STAT3 or STAT3.
femoral muscle, heart, and liver revealed no expression To substantiate this hypothesis, we conducted elec-
trophoretic mobility shift assays (EMSA) with digoxi-of the GFAP gene (data not shown). We then examined
the frequency of methylation in these tissues of the CpG genin-labeled oligonucleotides containing the STAT3
binding site (1518 to 1510) in the GFAP promoterdinucleotide in the STAT3 binding element (1518 to
1510) critical for GFAP expression, and found that this (*GFS3) and its methylated form (*GFS3-Me). As a source
of activated or control STAT3 protein, cell lysates wereelement was almost completely methylated (Figure 3A,
columns 4–6). These results further suggest a close cor- prepared from LIF-stimulated or nonstimulated COS7
cells which had been infected with recombinant adeno-relation between GFAP expression and the methylation
of the CpG site in the STAT3 binding element, which is virus expressing STAT3. As shown in Figure 4A, *GFS3
formed a complex with LIF-stimulated, STAT3-con-applicable within and outside the nervous system.
taining lysates. This complex disappeared after the ad-
dition of a 100-fold excess of unlabeled probe (GFS3). InImpairment of STAT3 Binding to the Methylated
Recognition Sequence contrast, the addition of a 100-fold excess of methylated
oligonucleotide (GFS3-Me) did not affect the complexIn exerting transcriptional activation, it is essential for
STAT3 to bind to its recognition sequence present in formation. Furthermore, incubation with anti-STAT3 an-
tibody led to retardation of the electrophoretic mobilitythe target gene promoters. The foregoing results showed
that the CpG dinucleotide in the STAT3 binding site was of the complex, proving the presence of STAT3 protein
in the complex. The methylated probe (*GFS3-Me) neverhighly methylated in cells devoid of GFAP expression,
suggesting that the methylation in the STAT3 binding formed a complex with STAT3 regardless of LIF stimula-
tion. These results clearly demonstrate that STAT3 iselement impedes accessibility of STAT3.
Methylation-Regulated Astrocyte Differentiation
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should be noted that even in the former cell type, STAT3
is activated (see Figure 2H). Immune complexes were
prepared from the cell lysates using an anti-STAT3 anti-
body, and DNA fragments coprecipitated with STAT3
were examined by PCR for the presence of the GFAP
promoter sequence. The data in Figure 4B (right-hand 4
lanes) provide clear evidence for an interaction between
STAT3 and the relevant region of the GFAP promoter in
LIF-stimulated neural precursors. In contrast, the inter-
action was hardly detectable in postmitotic neurons
(Figure 4B, left-hand 4 lanes) which had the highly meth-Figure 3. Cell Type-Specific and Developmental Stage-Dependent
CpG Methylation in the STAT3 Binding Site in the GFAP Gene Pro- ylated STAT3 binding element in the GFAP promoter
moter (see Figure 3A), even though STAT3 is activated in re-
(A) CpG methylation in the STAT3 recognition sequence (1518 to sponse to LIF (see Figure 2H). These results further sug-
1510) of the GFAP promoter investigated by bisulfite sequencing gest that STAT3 is unable to bind to the methylated form
in postmitotic neurons (column 1), proliferating neural precursors of its recognition sequence in the GFAP promoter both
(column 2), and astrocytes (column 3), each prepared from E14.5
in vitro and in vivo.mouse telencephalon, and from adult femoral muscle (column 4),
heart (column 5), and liver (column 6). PCRs were independently
performed 3 times for each sample, then cloned. Frequencies of Transcriptional Unresponsiveness of the GFAP
clones having methylation in the STAT3 recognition sequence are
Promoter with Methylated STAT3expressed as a percentage of the total number of clones sequenced
Recognition Sequence(10 to 14 clones) for each independent PCR. The average methyla-
tion frequency in every cell type was calculated based on the We and others have shown that the STAT3 binding se-
frequency values derived from the three PCRs. Vertical bar repre- quence located between 1518 and 1510 is a prereq-
sents SD. uisite for GFAP gene expression, and we have demon-
(B) The STAT3 recognition sequence in the GFAP promoter investi- strated in this paper that methylation of this sequence
gated for its methylation status in neuroepithelial cells in freshly
interferes with STAT3 binding. We next attempted toprepared E11.5 (closed circle) or E14.5 (open circle) mouse telencepha-
examine whether methylation of the STAT3 binding ele-lon or after 4 days in in vitro culture. Vertical bar represents SD.
ment does indeed result in the inhibition of STAT3-medi-
ated promoter activation. To this end, promoter assays
were conducted with a reporter construct containing 8incapable of binding to the methylated form of its recog-
nition sequence. repeats of the STAT3 binding element appended to the
minimal promoter region of the GFAP gene (SBS8GFMP;To confirm whether this methylation-mediated inter-
ference with STAT3 binding takes place in vivo, we per- see Figure 2A). Since it has been reported that various
kinds of methylated CpG binding proteins exist in mam-formed chromatin immunoprecipitation (ChIP) assays
with postmitotic neurons or proliferating neural precur- malian cells and confer nonspecific transcriptional re-
pression to or below the detection limit (Bird and Wolffe,sors which are incapable or capable, respectively, of
expressing GFAP in response to LIF stimulation. It 1999), we employed Drosophila melanogaster cells in
Table 1. Methylation Frequency in the STAT3 Binding Site in the GFAP Promoter
Proliferating Neural
Postmitotic Precursors (E14.5 after Femoral
PCR Neurons 4 Days Culture) Astrocytes Muscle Heart Liver
#1 Methylated CpG 10 0 2 9 11 11
n 11 10 10 10 12 11
Percent 90.9% 0.0% 20.0% 90.0% 91.7% 100.0%
#2 Methylated CpG 8 1 1 11 8 9
n 10 11 11 11 10 10
Percent 80.0% 9.1% 9.1% 100.0% 80.0% 90.0%
#3 Methylated CpG 8 2 1 10 10 9
n 10 14 13 10 12 10
Percent 80.0% 14.3% 7.7% 100.0% 83.3% 90.0%
E11.5 after
PCR E11.5 E14.5 4 Days Culture
#1 Methylated CpG 11 5 7
n 13 10 13
Percent 84.6% 50.0% 53.8%
#2 Methylated CpG 10 3 8
n 13 12 13
Percent 76.9% 25.0% 61.5%
#3 Methylated CpG 10 4 8
n 11 10 12
Percent 90.9% 40.0% 66.7%
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Figure 4. Impairment of STAT3 Binding to the
Methylated Form of Its Target Sequence
(A) Electrophoretic mobility shift assay per-
formed using a digoxigenin-labeled probe
containing 3 tandem repeats of STAT3 recog-
nition sequences (*GFS3) and its methylated
version (*GFS3-Me). A 100-fold excess of
nonlabeled GFS3 and GFS3-Me (X100 GFS3
and X100 GFS3-Me) were used as competi-
tors. An antibody against STAT3 was used.
(B) Chromatin immunoprecipitation assay
performed using formaldehyde-cross-linked,
moderately sonicated chromatin from non-
stimulated () or LIF-stimulated () postmi-
totic neurons (PMNs) and neural precursor
cells (NPCs). The DNA fragments of the GFAP
promoter associated with STAT3 were immu-
noprecipitated using an antibody against
STAT3, and detected using PCR. The GFAP
promoter fragment was detected in the anti-
STAT3 immunoprecipitate obtained from LIF-
stimulated neural precursor cells.
this study (SL2 cells) since these are considered to have 5-aza-CdR. This finding further confirms that unrespon-
siveness of E11.5 neuroepithelial cells to gliogenic signalfew methyl binding proteins. We first examined whether
STAT3 could be activated by joint expression with JAK1, is attributable to DNA methylation.
a cytoplasmic tyrosine kinase functioning upstream of
STAT3, in SL2 cells. Western blot analysis revealed that Discussion
simultaneous expression of STAT3 and JAK1 resulted in
activation of both proteins as assessed by their tyrosine- As we and others previously demonstrated, the gp130-
phosphorylation status (Figure 5A). The CpG-methyl- STAT3 signaling pathway is critical for astrocyte differ-
ated form of the SBS8GFMP reporter was prepared by entiation from neuroepithelial cells (Bonni et al., 1997;
treatment with SssI in vitro. After the treatment with Nakashima et al., 1999a; Takizawa et al., 2001). How-
SssI, SBS8GFMP became resistant to HpaII digestion ever, it is obvious that this signaling pathway does not
(Figure 5B), indicating that methylation was accom- automatically force the cells to induce astrocytes. As
plished successfully. Methylated or unmethylated SBS8- shown in the present work, postmitotic neurons do not
GFMP were cotransfected into SL2 cells along with an express the astrocytic marker GFAP even though STAT3
empty vector or a set of JAK1 and STAT3 expression is activated. The same is true for neuroepithelial cells
vectors. As shown in Figure 5C, methylation of SBS8GFMP at a relatively early developmental stage, for instance
significantly impeded STAT3-mediated transcriptional on E11.5. In these cell types, the STAT3 binding element
activation. Since the response of SBS8GFMP to STAT3 critical for GFAP expression is shown here to be methyl-
activation was fully dependent on the STAT3 binding ated. The current work thus supports the important hy-
sequence, TTCCGAGAA, within the construct (Figure pothesis that cell lineage specification in the developing
2A), it is conceivable that the reduced response of meth- brain is regulated by both cell-external cues and cell-
ylated SBS8GFMP to STAT3 activation can be attributed intrinsic programs, where the former involves gp130 cy-
to the methylation in the sequence. tokines and the latter involves the methylation status of
the promoter of the gene for astrocyte-specific protein
GFAP in this case. It is worth noting that methylation ofDemethylation Confers Responsiveness to
Gliogenic Signal on E11.5 Neuroepithelial Cells the STAT3 binding element abolishes the accessibility of
STAT3 and concomitantly inhibits transcription activity.To verify the inhibitory role of methylation in GFAP ex-
pression, we incubated E11.5 neuroepithelial cells, Thus, both external and internal cellular conditions ap-
pear to cooperate in determining lineage specification.which do not normally express GFAP in response to LIF
(see Figure 1), with LIF in the presence or absence of In this sense, it appears likely that methylation of the
STAT3 binding element in the GFAP gene promoter musta demethylating agent, 5-aza-2-deoxycytidine (5-aza-
CdR). As shown in Figure 6, GFAP-expressing cells ap- become less frequent in E14.5 neuroepithelial cells from
which astrocytes are readily differentiated in the 4-daypeared in response to LIF only in the culture containing
Methylation-Regulated Astrocyte Differentiation
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Figure 6. Precocious Acquisition of Responsiveness to Gliogenic
Signal of E11.5 Neuroepithelial Cells by Forced Demethylation
(A and B) Neuroepithelial cells prepared from E11.5 mouse telen-
cephalons cultured with LIF (80 ng/ml) for 4 days in the presence
(B) or absence (A) of 5-aza-CdR (3 M).
Cells were stained with antibodies against GFAP (red) or MAP2
(green). Bar  50 m.
promoter is almost completely methylated in such tis-
sues as muscle, heart, and liver, CpG methylation
appears to function to avoid expression of genes at
undesirable times and places. In conclusion, CpG meth-
ylation may be important not only in gene silencing but
also in the timing of fate determination of neural precur-
sors in the developing brain. The cell-fate switch of neu-
ral precursors may, in part, be attributable to the de-
methylation of methylated CpG sites. If it is the case,
CpG methylation may occur simultaneously over whole
genomic loci containing astrocyte-specific gene pro-
moters in cells committed to becoming non-astrocytic
Figure 5. Methylation-Dependent Inhibition of STAT3-Induced cell types.
Transcriptional Activation Our results demonstrate that methylation in the STAT3
(A) SL2 cells cotransfected with pAC5.1-JAK1 along with pAC5.1- recognition sequence abolishes binding of STAT3, lead-
STAT3. Cell lysates were subjected to immunoprecipitation with ing to transcriptional inhibition of STAT3-induced GFAP
antibodies against JAK1 and STAT3, followed by immunoblotting gene expression. There is an alternative mechanism
with an anti-phosphotyrosine antibody. The presence of JAK1 and
whereby methylation confers gene suppression, namelySTAT3 were confirmed by blotting with either anti-JAK1 or anti-
methyl-CpG binding protein-mediated gene silencing.STAT3.
MeCP2, for instance, is a member of a group of methyl-(B) Methylation of the reporter construct SBS8GFMP performed with
SssI in vitro and confirmed by digesting with the methyl-sensitive ated-CpG binding proteins and is expressed at high
enzyme, HpaII. levels in the postnatal brain (Coy et al., 1999; Lewis et
(C) Methylated or unmethylated SBS8GFMP cotransfected with ei- al., 1992). It has been demonstrated that MeCP2 confers
ther a combination of pAC5.1-JAK1 and pAC5.1-STAT3 or vehicle
transcriptional repression via association with HDACsalone into SL2 cells and cell lysates analyzed for luciferase activity.
(Jones et al., 1998). While it remains unknown whetherResults are presented as the percentage increase in activity induced
MeCP2 actually occupies the methylated STAT3 recog-by JAK1-STAT3 coexpression in comparison with the control (vehi-
cle transfection). nition sequence in the GFAP gene promoter in postmi-
totic neurons, we can say that, at least for the GFAP
expression, reduction in the STAT3 binding affinity forstimulation with gp130-stimulating cytokines. It is inter-
its target sequence by CpG methylation is sufficient foresting to note that E11.5 neuroepithelial cells became
silencing the GFAP gene. In humans, mutations in theresponsive to LIF-induced expression of GFAP, when
MeCP2 gene cause Rett syndrome (RTT), a childhoodthe cells were cultured for 4 days in vitro prior to LIF
neurological disorder (Dragich et al., 2000; Van denstimulation (M.N. et al., unpublished data). These find-
Veyver and Zoghbi, 2000). Mice deficient for MeCP2ings support the hypothesis that developmental
show symptoms which resemble those of RTT patientschanges in responsiveness to a certain external signal
and a decrease in the size of hippocampal neuronsare determined by the methylation status in the promoter
(Chen et al., 2001; Guy et al., 2001). These facts implyregion of the signal’s target gene(s). This is also strongly
that MeCP2 plays important and nonredundant roles insupported by the results that demethylation by 5-aza-
the normal function of the nervous system.CdR led to the acquisition of precocious responsiveness
As for the enzymes involved in the methylation of theof E11.5 neuroepithelial cells to gliogenic signal (see
CpG dinucleotide, there are two different types of DNAFigure 6). This mechanism is of great importance in
methyltransferase, among which Dnmt1 is a mainte-understanding cell lineage specification during the de-
nance type of DNA methyltransferase (Lyko et al., 1999),velopment of the brain where various kinds of cell-exter-
and Dnmt3a and Dnmt3b are de novo DNA methyltrans-nal cues (i.e., growth and differentiation factors) are
ferases (Okano et al., 1999). These enzymes are consid-present simultaneously. Taken together with the obser-
vation that the STAT3 binding site in the GFAP gene ered to be required for prohibiting undesirable gene
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basic FGF (R&D Systems) (N2/DMEM/F12/bFGF) on culture dishesexpression or maintaining the stability of chromatin
which had been precoated with poly-L-ornithine (Sigma) and fibro-structures (Bestor, 2000). Analysis of conditional mutant
nectin (Life Technologies). For selection of postmitotic neurons, 1mice lacking Dnmt1 in mitotic CNS precursor cells re-
M AraC was added to the culture media.
vealed that hypomethylated CNS neurons failed to ex-
hibit appropriate function and were excluded at postna- Recombinant Adenovirus Construction and Infection
tal stages by as yet unknown mechanisms (Fan et al., Recombinant adenoviruses were constructed as described pre-
viously (Saitoh et al., 1998). Infection of neuroepithelial cells with2001), implying the importance of CpG methylation for
each recombinant adenovirus was performed at a multiplicity ofneurons. It is interesting to note that treatment with 5-
infection (MOI) of 200 PFU/cell.aza-CdR led to induction of GFAP expression in mouse
fibroblasts which do not normally express GFAP (Micha-
Immunofluorescent Staining
lowsky and Jones, 1989). This supports the involvement Cells cultured on chamber slides (Nunc) were washed with PBS,
of DNA methylation in cell-type-specific gene ex- fixed in 4% paraformaldehyde in PBS, and stained with one of the
pression. following primary antibodies: anti-GFAP (Dako), anti-MAP2 (Sigma),
anti-LacZ (Molecular Probes), or biotin-conjugated anti-FLAG (Sigma).Besides lineage specification, DNA methylation has
The following secondary antibodies were used: FITC-conjugatedbeen shown to be involved in the regulation of tumor
goat anti-mouse IgG, rhodamine-conjugated donkey anti-rabbit,cell growth. It has been reported that a promoter region
FITC-conjugated donkey anti-rabbit (Chemicon), and streptavidin-
of the gene for p21, an inhibitor of cyclin-dependent conjugated Texas Red (Vector). Nuclei were stained using bisben-
kinases, contains a recognition sequence for STAT1, zimide H33258 fluorochrome trihydrochloride (Nakaraitesque).
and that methylation in this sequence abolishes inter-
feron -induced expression of p21, resulting in the fail- Luciferase Assay
Neuroepithelial cells cultured for 4 days on 10 cm dishes, as de-ure of the growth arrest response in some tumor cell
scribed above, were replated on 12-well plates (Nunc) and trans-lines (Chen et al., 2000). Taken together with our current
fected the next day with the following reporter plasmids; GF1L,observations, methylation may be a pivotal event in de-
GF1L-SBSPM (Nakashima et al., 1999b), GFMP, or SBS8GFMP (see
termining the response of cells to the STAT family of Figure 2A). Control transfections were made using sea pansy lucifer-
proteins if their consensus binding sequences (TTNCN ase gene conjugated with human elongation factor 1	 promoter
NNAA) in the target gene promoters contain CpG dinu- (R-Luc) (Nakashima et al., 1999b). Transfections were performed
using Trans-It LT1 (Pan Vera) according to the manufacturer’s in-cleotides.
structions. On the following day, the cells were stimulated with LIFIt has long been asked why astrocytes appear at a
(80 ng/ml) for 8 hr and then solubilized. For Drosophila cells, STAT3very late stage of brain development whereas neurons
and JAK1 cDNA were subcloned into a pAC5.1 vector optimized for
are differentiated from nearly the beginning of neuroec- expression in Drosophila cells (pAc5.1-STAT3 and pAc5.1-JAK1).
toderm formation. As we have shown in this study, it is Either SssI-methylated or unmethylated SBS8GFMP was cotrans-
of interest that E11.5 neuroepithelial cells possess a fected with pAcSp1 (Courey and Tjian, 1988) and a combination of
pAc5.1-STAT3 and pAC5.1-JAK1 using a Cell Phect transfectioncomplete set of the gp130-STAT3 signaling machinery
kit (Amersham) according to the manufacturer’s instructions and(see Figure 2H) but do not differentiate into astrocytes
cultured for 24 hr. Luciferase activity was measured using the rec-even in the presence of gp130-stimulating cytokines.
ommended procedures for the Pikkagene Dual Luciferase Assay
More importantly, forced demethylation conferred pre- System (Tokyo Ink Inc.) with the following modification: trypsin inhib-
cocious responsiveness to an astrocyte-inducing cue, itor (1 mg/ml, type III-0 from soy bean white; Sigma) was included
LIF, upon the cells. Our present work sheds light on a in the cell lysis buffer. Sea pansy luciferase gene under a CMV
promoter (CMV-Renilla) was used as an internal control. A micromechanism by which developmental stage-dependent
Lumat LB96B luminometer (Wallac Berthold) was used for detection.cellular differentiation occurs. Our conclusion is that
STAT3 is a transcriptional factor sensitive to methylation
Immunoblottingin its target DNA sequence and that DNA methylation
Cells were lysed using NP40 lysis buffer (0.5% NP40, 10 mM Tris-
is important in the regulation of the gp130-STAT3 signal- HCl [pH 7.4], 150 mM NaCl, 3 mM pAPMSF [Wako Chemicals],
mediated astrocyte-specific gene expression. Our re- 5 mg/ml aprotinine (Sigma), 2 mM sodium orthovanadate [Wako
sults further suggest the mechanism underlying the cell Chemicals], and 5 mM EDTA). Lysates were immunoprecipitated
with anti-STAT3 (C-20; Santa Cruz) and anti-JAK1 (Santa Cruz) anti-type-specific and developmental stage-dependent re-
bodies. Immunoprecipitates and lysates were subjected to SDS-sponsiveness of cells to the STAT3-activation signal. To
PAGE and subsequent immunoblotting with antibodies againstelucidate the mechanism of how methylation or demeth-
STAT3 (Transduction Laboratories), tyrosine-phosphorylated STAT3
ylation of specific gene promoters is regulated during (Cell Signaling), JAK1, or phospho-tyrosine (4G10; Upstate Biotech-
development will be an intriguing subject for further nology). Detection was performed using the ECL detection system
study, and will pave the way for better understanding (Amersham).
of cell fate determination.
Bisulfite Sequencing
Sodium bisulfite treatment of genomic DNA was performed essen-Experimental Procedures
tially as described previously (Clark et al., 1994). Briefly, 5 g of
genomic DNA was digested with SacI, denatured with 0.3 M NaOHAnimals and Cell Preparation
Time-pregnant ICR mice were used to prepare neuroepithelial cells. at 37
C for 15 min, and incubated with 3.1 M sodium bisulfite and
0.5 mM hydroquinone at 55
C for 16 hr. The samples were purifiedMice were treated according to the guidelines of Kumamoto Univer-
sity Center for Animal Resources and Development. Neuroepithelial using a desalting column (Promega) according to the manufacturer’s
instructions, and eluted in 50 l of H2O. Three molar NaOH (5.5 l)cells were prepared from telencephalons of E11.5 or E14.5 mice
and cultured as described previously (Nakashima et al., 1999b). was added and the samples were incubated at 37
C for 15 min.
Samples were neutralized by the addition of 3 M ammonium acetate,Briefly, the telencephalons were triturated in Hank’s balanced salt
solution (HBSS) by mild pipetting with 1 ml pipet tip (Gilson). Dissoci- ethanol precipitated, and dissolved in H2O. The DNA fragment con-
taining the STAT3 recognition sequence was amplified by PCR usingated cells were cultured for 4 days in N2-supplemented Dulbecco’s
Modified Eagle’s Medium with F12 (GIBCO) containing 10 ng/ml the following set of primers: GFmS; 5-GGGATTTATTAGGAGAATT
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TTAGTAAGTAG-3, GFmAS; 5-TCTACCCATACTTAAACTTCTAA grant-in-aid for Scientific Research on Priority Areas (C) “Advanced
Brain Science Project,” “Dynamics of Developmental Systems,” andTATCTAC-3. The PCR products were cloned into pT7Blue and 10
to 14 clones randomly picked from each of three independent PCRs “Genome Biology” from the Ministry of Education, Culture, Sports,
Science and Technology, Japan; the Takeda Science Foundation;were sequenced.
and the Human Frontier Science Program.
Electrophoretic Mobility Shift Assay
COS7 cells were infected with a recombinant adenovirus engineered Received September 17, 2001; revised November 2, 2001.
to express STAT3 and cultured for 16 hr. After stimulation with LIF
(80 ng/ml) for 15 min, cells were lysed in lysis buffer (0.1% NP-40, References
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